To
Totus Med
Cambridge MAFounded 202130 employees
Private CapbiotechPrivateOncology
Platform: TCR-T
Market Cap
N/A
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Cevilemzoparlimab | TOT-5774 | Preclinical | 2 | HER2 | NMOSD | ||
| TOT-3942 | TOT-3942 | Preclinical | 2 | PI3Kα | GA |
Financial Documents
This is a private company — SEC filings are not available.
Catalyst Events (5)